Clinical Trial Update: To Evaluate the Beneficial Effect of Probiotics on DKD Patients and the Role of Gut Microbiota Modulation [NA]

View source ↗

Summary

A completed clinical trial evaluating whether probiotics can benefit patients with diabetic kidney disease and exploring the role of gut microbiota modulation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Kidney Disease

Drugs mentioned

• Probiotics

Snippet

Sponsor: GenMont Biotech Incorporation | Conditions: Diabetic Kidney Disease | NA | Status: COMPLETED